Market revenue in 2024 | USD 720.7 million |
Market revenue in 2030 | USD 1,055.9 million |
Growth rate | 6.6% (CAGR from 2024 to 2030) |
Largest segment | Consumables |
Fastest growing segment | Rapid Testing Devices |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments, Rapid Testing Devices, Services |
Key market players worldwide | Quest Diagnostics Inc, Abbott Laboratories, QuidelOrtho Corp, Roche Holding AG ADR, Thermo Fisher Scientific Inc, Siemens Healthineers AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Labcorp Holdings Inc, Clinical Reference Laboratory, Cordant Health Solutions, Legacy Medical, Draegerwerk AG & Co KGaA, Omega Laboratories |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug testing market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 34.62% in 2024. Horizon Databook has segmented the China drug testing market based on consumables, instruments, rapid testing devices, services covering the revenue growth of each sub-segment from 2018 to 2030.
In China, drug abuse, especially alcohol and illicit drug abuse, is very common among young people. Moreover, the growth of China drug testing market can also be attributed to increasing number of product launches and growing availability of rapid test kits.
For instance, in March 2021, the Hong Kong police force deployed DrugWipe 6 S Ketamine for rapid screening tests for roadside drug screening. The device provides rapid screening for seven drugs—opiates, cannabis, amphetamines, cocaine, benzodiazepines, methamphetamines (MDMA, ecstasy), and ketamine.
The Chinese government is proactively taking steps to control the spread and consumption of illicit drugs in the country. As per the "Drug Control Law of the People's Republic of China," the National Narcotics Control Commission (NNCC) is responsible for monitoring, coordinating, and organizing national drug control work.
Horizon Databook provides a detailed overview of country-level data and insights on the China drug testing market , including forecasts for subscribers. This country databook contains high-level insights into China drug testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account